Treatment Experiences of Latinas After Diagnosis Of Breast Cancer

Katz, Steven J.; Wallner, Lauren P.; Abrahamse, Paul H.; Janz, Nancy K.; Martinez, Kathryn A.; Shumway, Dean A.; Hamilton, Ann S.; Ward, Kevin C.; Resnicow, Kenneth A.; Hawley, Sarah T.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Treatment Experiences of Latinas After Diagnosis Of Breast Cancer

Published Date:

Apr 11 2017

Source:

Cancer. 123(16):3022-3030.

Language:

English

[PDF-169.62 KB]

Details:

Alternative Title:

Cancer

Personal Author:

Katz, Steven J. ; Wallner, Lauren P. ; Abrahamse, Paul H. ; Janz, Nancy K. ; Martinez, Kathryn A. ; ... More ▼

Description:

Objectives

We examined race/ethnic differences in patient perspectives about their breast cancer treatment experiences.

Methods

A weighted random sample of women newly diagnosed with breast cancer in 2013–15 in Los Angeles County and Georgia were sent surveys 2 months after surgery (N=5,080, 70% response rate). The analytic sample was limited to patients in Los Angeles County (N=2,397).

Results

The pattern of visits with different specialists before surgery was similar across race/ethnic groups. Low acculturated Latinas (Latinas-LA) were less likely to report high clinician communication quality for both surgeons and medical oncologists (under 69% vs over 72% for all other groups, p<.05). The proportion of patients who reported high satisfaction about how doctors worked together was similar across race/ethnic groups. Latinas-LA were more likely to have a low autonomy decision style (48% vs 24%–50% for all other groups, p<.001) and were more likely to report getting too much information vs other ethnic groups (20% vs <16% for other groups, p<.001). Patients who reported a low autonomy decision style were more likely to rate amount of information received for the surgery decision as “too much” (16% vs 9%, p<.001).

Conclusions

There is moderate disparity in breast cancer treatment communication and decision making experiences reported by Latinas with low acculturation vs other groups. The approach to treatment decision making by Latinas with low acculturation represents an important challenge to health care providers. Initiatives are needed to improve patient engagement in decision-making and increase clinician awareness of these challenges in this patient population.

Subject:

[+]

Pubmed ID:

28398629

Pubmed Central ID:

PMC5544545

Document Type:

Journal Article

Funding:

HHSN261201000140C/CA/NCI NIH HHS/United States ; HHSN261201000035C/CA/NCI NIH HHS/United States ; P01 CA163233/CA/NCI NIH HHS/United States ; U58 DP003875/DP/NCCDPHP CDC HHS/United States ; HHSN261201300015C/RC/CCR NIH HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	NIHMS860268-supplement-Supp_Fig_S1.tiff	image/tiff
	nihms860268.nxml	text/xml
	nihms860268f1a.gif	image/gif
	nihms860268f1a.jpg	image/jpeg
	nihms860268f1b.gif	image/gif
	nihms860268f1b.jpg	image/jpeg
	nihms860268f2.gif	image/gif
	nihms860268f2.jpg	image/jpeg

No Related Documents.

You May Also Like:

Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer

Personal Author:

Jagsi, Reshma; Ward, Kevin C.; Abrahamse, Paul; Wallner, Lauren P.; Kurian, Allison W.; Hamilton, Ann S.; Katz, Steven J.; Hawley, Sarah T.;

Published Date:

July 23 2018

Source:

Cancer. 124(18):3668-3676

Description:

Background:Little is known about whether growing awareness of the financial toxicity of cancer diagnosis and treatment has increased clinician engagement or changed current patients’ needs.Methods:We surveyed patients with early-stage breast cancer...

File Type:

[PDF - 432.69 KB]
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women

Personal Author:

Parikh, Aparna R.; Kaplan, Celia Patricia; Burke, Nancy J.; Livaudais-Toman, Jennifer; Hwang, E. Shelley; Karliner, Leah S.;

Published Date:

September 01 2013

Source:

Breast Cancer Res Treat. 141(2):261-268

Description:

While not itself life-threatening, ductal carcinoma in situ (DCIS) can progress to invasive disease if untreated, and confers an increased risk of future breast cancer. We investigated knowledge of DCIS among a cohort of English- and Spanish-speaking...

File Type:

[PDF - 137.17 KB]
Providers of Follow-Up Care in a Population-Based Sample of Breast Cancer Survivors

Personal Author:

Friese, Christopher R.; Martinez, Kathryn A.; Abrahamse, Paul; Hamilton, Ann S.; Graff, John J.; Jagsi, Reshma; Griggs, Jennifer J.; Hawley, Sarah T.; Katz, Steven J.;

Published Date:

Jan 31 2014

Source:

Breast Cancer Res Treat. 144(1):179-184

Description:

PurposeTo describe which providers provide breast cancer survivorship care.Patients and MethodsWe conducted a longitudinal survey of non-metastatic breast cancer patients identified by the SEER registries of Los Angeles and Detroit. Multinomial logis...

File Type:

[PDF - 152.67 KB]
Adjuvant Endocrine Therapy Initiation and Persistence in a Diverse Sample of Patients with Breast Cancer

Personal Author:

Friese, Christopher R.; Pini, T. May; Li, Yun; Abrahamse, Paul H.; Graff, John J.; Hamilton, Ann S.; Jagsi, Reshma; Janz, Nancy K.; Hawley, Sarah T.; Katz, Steven J.; Griggs, Jennifer J.;

Published Date:

Mar 31 2013

Source:

Breast Cancer Res Treat. 138(3):931-939.

Description:

BackgroundAdjuvant endocrine therapy for breast cancer reduces recurrence and improves survival rates. Many patients never start treatment or discontinue prematurely. A better understanding of factors associated with endocrine therapy initiation and ...

File Type:

[PDF - 271.19 KB]
Chemotherapy Decisions and Patient Experience with the Recurrence Score Assay for Early-Stage Breast Cancer

Personal Author:

Friese, Christopher R.; Li, Yun; Bondarenko, Irina; Hofer, Timothy; Ward, Kevin C.; Hamilton, Ann S.; Deapen, Dennis; Kurian, Allison W.; Katz, Steven J.;

Published Date:

Oct 24 2016

Source:

Cancer. 123(1):43-51.

Description:

BackgroundThe 21-gene recurrence score assay (RS) stratifies early-stage, estrogen receptor-positive breast cancer by recurrence risk. Few studies have examined how physicians use RS to recommend adjuvant systemic chemotherapy or patient experiences ...

File Type:

[PDF - 471.05 KB]